Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $166.65 | 9 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | $54.07 | 3 | $0 (2024) |
| UCB, Inc. | $39.25 | 2 | $0 (2024) |
| Amgen Inc. | $27.82 | 1 | $0 (2024) |
| Blueprint Medicines Corporation | $16.65 | 1 | $0 (2024) |
| Arcutis Biotherapeutics, Inc. | $14.71 | 1 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $14.15 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $166.65 | 9 | SUN PHARMACEUTICAL INDUSTRIES INC. ($54.07) |
All Payment Transactions
9 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: Dermatology | ||||||
| 12/11/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: Dermatology | ||||||
| 12/05/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: Immunology | ||||||
| 11/12/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: Dermatology | ||||||
| 10/16/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: Immunology | ||||||
| 09/11/2024 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | Cash or cash equivalent | $16.65 | General |
| Category: Oncology / Rare Diseases | ||||||
| 09/05/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/14/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $27.82 | General |
| Category: Inflammation | ||||||
| 08/09/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: Dermatology | ||||||
About Rebecca Youssef, PA-C
Rebecca Youssef, PA-C is a Physician Assistant healthcare provider based in Airmont, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/02/2024. The National Provider Identifier (NPI) number assigned to this provider is 1689404956.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Rebecca Youssef, PA-C has received a total of $166.65 in payments from pharmaceutical and medical device companies, with $166.65 received in 2024. These payments were reported across 9 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($166.65).
Practice Information
- Specialty Physician Assistant
- Location Airmont, NY
- Active Since 08/02/2024
- Last Updated 08/02/2024
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1689404956
Products in Payments
- Bimzelx (Biological) $39.25
- Winlevi (Drug) $36.52
- Otezla (Drug) $27.82
- ILUMYA (Biological) $17.55
- AYVAKIT (Drug) $16.65
- Zoryve (Drug) $14.71
- DUPIXENT (Biological) $14.15
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.